Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy


Autoria(s): Luizon, Marcelo Rizzatti; Sandrim, Valéria Cristina; Palei, Ana Carolina Taveiros; Lacchini, Riccardo; Cavalli, Ricardo de Carvalho; Duarte, Geraldo; Santos, Jose Eduardo Tanus dos
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

05/11/2013

05/11/2013

2012

Resumo

Polymorphisms of the endothelial nitric oxide synthase (eNOS), matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF) genes were shown to be associated with hypertensive disorders of pregnancy. However, epistasis is suggested to be an important component of the genetic susceptibility to preeclampsia (PE). The aim of this study was to characterize the interactions among these genes in PE and gestational hypertension (GH). Seven clinically relevant polymorphisms of eNOS (T-786C, rs2070744, a variable number of tandem repeats in intron 4 and Glu298Asp, rs1799983), MMP-9 (C-1562T, rs3918242 and -90(CA)(13-25), rs2234681) and VEGF (C-2578A, rs699947 and G-634C, rs2010963) were genotyped by TaqMan allelic discrimination assays or PCR and fragment separation by electrophoresis in 122 patients with PE, 107 patients with GH and a control group of 102 normotensive pregnant (NP) women. A robust multifactor dimensionality reduction analysis was used to characterize gene-gene interactions. Although no significant genotype combinations were observed for the comparison between the GH and NP groups (P>0.05), the combination of MMP-9-1562CC with VEGF-634GG was more frequent in NP women than in women with PE (P<0.05). Moreover, the combination of MMP-9-1562CC with VEGF-634CC or MMP-9-1562CT with VEGF-634CC or-634GG was more frequent in women with PE than in NP women (P<0.05). These results are obscured when single polymorphisms in these genes are considered and suggest that specific genotype combinations of MMP-9 and VEGF contribute to PE susceptibility. Hypertension Research (2012) 35, 917-921; doi:10.1038/hr.2012.60; published online 10 May 2012

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil

Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil

Identificador

HYPERTENSION RESEARCH, LONDON, v. 35, n. 9,pp. 917-921, SEP, 2012

0916-9636

http://www.producao.usp.br/handle/BDPI/41437

10.1038/hr.2012.60

http://dx.doi.org/10.1038/hr.2012.60

Idioma(s)

eng

Publicador

NATURE PUBLISHING GROUP

LONDON

Relação

HYPERTENSION RESEARCH

Direitos

closedAccess

Copyright NATURE PUBLISHING GROUP

Palavras-Chave #ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE #EPISTASIS #MATRIX METALLOPROTEINASE-9 GENE #PREECLAMPSIA #VASCULAR ENDOTHELIAL GROWTH FACTOR GENE #MULTIFACTOR-DIMENSIONALITY REDUCTION #ENDOTHELIAL GROWTH-FACTOR #GENE-GENE INTERACTIONS #GESTATIONAL HYPERTENSION #MATRIX METALLOPROTEINASES #ANTIANGIOGENIC FACTORS #HUMAN TROPHOBLASTS #TISSUE INHIBITORS #TYROSINE KINASE-1 #PREECLAMPSIA #PERIPHERAL VASCULAR DISEASE
Tipo

article

original article

publishedVersion